COMBIVENT RESPIMAT- ipratropium bromide and albuterol spray, metered United States - English - NLM (National Library of Medicine)

combivent respimat- ipratropium bromide and albuterol spray, metered

boehringer ingelheim pharmaceuticals inc. - ipratropium bromide (unii: j697uz2a9j) (ipratropium - unii:gr88g0i6ul), albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - ipratropium bromide anhydrous 20 ug - combivent respimat is a combination of ipratropium bromide (an anticholinergic agent) and albuterol sulfate (a beta2 -adrenergic agonist) indicated for use in patients with chronic obstructive pulmonary disease (copd) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator. combivent respimat is contraindicated in the following conditions [see warnings and precautions (5.6) ]: - hypersensitivity to any of the ingredients in combivent respimat - hypersensitivity to atropine or any of its derivatives risk summary there are no randomized clinical studies of combivent respimat, or its individual components, ipratropium bromide and albuterol sulfate, in pregnant women. ipratropium is negligibly absorbed systemically following oral inhalation; therefore, maternal use is not expected to result in fetal exposure to the drug [see clinical pharmacology (12.3)] . published literature, including cohort studies, case control studies and case series, over s

Combiprasal 0.5 mg/2.5 mg per 2.5 ml nebuliser solution Ireland - English - HPRA (Health Products Regulatory Authority)

combiprasal 0.5 mg/2.5 mg per 2.5 ml nebuliser solution

pharma stulln gmbh - ipratropium bromide; salbutamol sulfate - nebuliser solution - 0.5 mg/2.5 milligram(s) - adrenergics in combination with anticholinergics; salbutamol and ipratropium bromide

IPRAMOL STERI-NEB Ireland - English - HPRA (Health Products Regulatory Authority)

ipramol steri-neb

norton healthcare limited t/a ivax pharmaceuticals uk - ipratropium bromide monohydrate ; salbutamol sulfate - nebuliser solution - 0.5/2.5 mg/mg - salbutamol and ipratropium bromide

Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules

actavis uk ltd - ipratropium bromide; salbutamol sulfate - nebuliser liquid - 200microgram/1ml ; 1mg/1ml

IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE solution United States - English - NLM (National Library of Medicine)

ipratropium bromide and albuterol sulfate solution

the ritedose corporation - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e), ipratropium bromide (unii: j697uz2a9j) (ipratropium - unii:gr88g0i6ul) -

IPRATROPIUM STERI-NEB Ireland - English - HPRA (Health Products Regulatory Authority)

ipratropium steri-neb

norton healthcare limited t/a ivax pharmaceuticals uk - ipratropium bromide - nebuliser solution - 250 microgram/ml - ipratropium bromide

Ipramol Steri-Neb 0.5 mg/2.5 mg per 2.5 ml nebuliser solution Ireland - English - HPRA (Health Products Regulatory Authority)

ipramol steri-neb 0.5 mg/2.5 mg per 2.5 ml nebuliser solution

teva b.v. - ipratropium bromide; salbutamol sulfate - nebuliser solution - 0.5/2.5 mg/mg - adrenergics in combination with anticholinergics; salbutamol and ipratropium bromide

ZERSEOS Ireland - English - HPRA (Health Products Regulatory Authority)

zerseos

cipla (eu) limited - ipratropium bromide monohydrate ; salbutamol sulfate - nebuliser solution - 0.5mg/2.5 milligram - salbutamol and sodium cromoglicate